프레스티지바이오로직스 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 김 마이클 진우, was filed 10 Jul 2026.
프레스티지바이오로직스: what insiders have been doing
Every trade that managers of 프레스티지바이오로직스 disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. Between 9 November 2025 and 9 November 2026, 2 insiders published 3 filings.
Every open-market trade in the period is a purchase: 3 purchases, from 2 insiders, and not a single sale. The amount is not disclosed for 3 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Those buying include 1 major shareholder and 1 chief executive.
With 3 filings in twelve months, the company is quieter than the median of 7 filings across the 2,657 companies we follow on the same exchange. Looking back to 2021, when coverage begins, insiders filed 39 purchases and 1 sale.
The most recent open-market purchase was published on 10 July 2026, 123 days ago.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and Vetoquinol SA. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- -12.8%Entry ₩4,350 · Close at T+365 ₩3,795
- -12.8%Entry ₩4,350 · Close at T+365 ₩3,795
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2026FY ended June 2026 · cache
- Other0DART
- Other0DART
- 3,600 sharesShareKRXDART:20260710000177Canonical exit: 8 Oct 2026 (T+90)
- 103,600 sharesKRXDART:20260710000176Canonical exit: 8 Oct 2026 (T+90)
- 100,000 sharesShareKRXDART:20260630000128Canonical exit: 28 Sept 2026 (T+90)
- 35,000 sharesShareKRXDART:20250604000195Canonical exit: 2 Sept 2025 (T+90)
- 15,916,168 sharesKRXDART:20240927000731Canonical exit: 24 Dec 2024 (T+90)
- ShareKRXDART:20240927000751Canonical exit: 24 Dec 2024 (T+90)
- 80,000 shares@ ₩3,330.00100.0% of flowShareKRXDART:20240405003707Canonical exit: 27 Jun 2024 (T+90)
- 22,500 shares@ ₩3,330.00100.0% of flowShareKRXDART:20240405003667Canonical exit: 27 Jun 2024 (T+90)
- 102,500 sharesKRXDART:20240405003841Canonical exit: 30 Jun 2024 (T+90)
- ShareKRXDART:20231222000185Canonical exit: 19 Mar 2024 (T+90)
- ShareKRXDART:20231222000181Canonical exit: 19 Mar 2024 (T+90)
- 15,916,168 sharesKRXDART:20231219000013Canonical exit: 17 Mar 2024 (T+90)
- 15,916,168 sharesKRXDART:20231215000446Canonical exit: 10 Mar 2024 (T+90)
- ShareKRXDART:20230525000078Canonical exit: 20 Aug 2023 (T+90)
- 15,916,168 sharesKRXDART:20230523000020Canonical exit: 16 Aug 2023 (T+90)
- ShareKRXDART:20230404002700Canonical exit: 3 Jul 2023 (T+90)
- 15,916,168 sharesKRXDART:20230324001123Canonical exit: 22 Jun 2023 (T+90)
- 15,916,168 sharesKRXDART:20230306000361Canonical exit: 4 Jun 2023 (T+90)
- 792,632 sharesKRXDART:20230213000893
- 15,916,168 sharesKRXDART:20221230000465Canonical exit: 30 Mar 2023 (T+90)
- 15,916,168 sharesKRXDART:20221222000028Canonical exit: 22 Mar 2023 (T+90)
- ShareKRXDART:20220915000499Canonical exit: 14 Dec 2022 (T+90)
- 15,916,168 sharesKRXDART:20220915000493Canonical exit: 14 Dec 2022 (T+90)
25 of 49 declarations
About 프레스티지바이오로직스
Prestige Biologics is a company specializing in the manufacturing of biological products for the pharmaceutical industry. It is listed on the XKRX market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
